Emtricitabine
Emtricitabine
Emtricitabine (pronounced as em-tri-SYE-ta-been) is an antiviral medication used to prevent and treat HIV/AIDS. It is often used in combination with other antiretroviral medications.
Etymology
The name "Emtricitabine" is derived from its chemical structure, which is a cytidine analogue. The "Em" refers to the ethyl group (C2H5) attached to the molecule, "tri" refers to the three fluorine atoms, and "citabine" is derived from cytidine.
Usage
Emtricitabine is used in combination with other antiretroviral drugs to treat HIV infection. It works by inhibiting the reverse transcriptase enzyme, which is crucial for the replication of HIV. By doing so, it helps to control the amount of HIV in the body, thereby helping the immune system to work better.
Side Effects
Common side effects of Emtricitabine include headache, diarrhea, nausea, and rash. Serious side effects may include liver disease, lactic acidosis, and worsening of hepatitis B among those already infected.
Related Terms
- Antiretroviral therapy: The use of drugs to manage HIV/AIDS.
- Reverse transcriptase inhibitor: A type of drug that inhibits the reverse transcriptase enzyme, which is crucial for the replication of HIV.
- HIV/AIDS: A disease caused by the human immunodeficiency virus.
See Also
- Tenofovir: Another antiretroviral medication often used in combination with Emtricitabine.
- Truvada: A medication that combines Emtricitabine and Tenofovir.
External links
- Medical encyclopedia article on Emtricitabine
- Wikipedia's article - Emtricitabine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski